Ofatumumab in AQP4-IgG Seropositive NMOSD

Clinical trial NCT05504694 · RECRUITING

Trial details

NCT number: NCT05504694
Sponsor: Tang-Du Hospital
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Neuromyelitis Optica Spectrum Disorder

Start date: 2022-06-28
Primary completion: 2026-04-30
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.